Selective Mutism
14
2
2
11
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
0.0%
0 terminated out of 14 trials
100.0%
+13.5% vs benchmark
0%
0 trials in Phase 3/4
18%
2 of 11 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 11 completed trials
Clinical Trials (14)
Implementing Team-Based Treatment for Pediatric Anxiety in Community Mental Health Settings
VR Homework Exercises for Selective Mutism Treatment
The Efficacy of Integrated Behavioral Therapy for Selective Mutism
Improving Access to Child Anxiety Treatment
Evaluating the Results of Physician and Parent Decisions to Treat Selective Mutism With Fluoxetine
Evaluating an Online Adjunctive Support Following Intensive Services (OASIS) Strategy for Youth With Selective Mutism
Factors Influencing Selective Mutism
Treatment of Social Anxiety Disorder and Selective Mutism
Evaluating Intensive Group Behavioral Treatment for Children With Selective Mutism
Integrated Behavioral Therapy for Treating Children With Selective Mutism
Brief Behavioral Treatment for Anxiety in Young Children
Randomised Controlled Treatment Study of Selective Mutism
Web-Based CBT Protocol for Treatment of Selective Mutism
What Treatment Works for Children With Selective Mutism?